Excellence in Research Award
Sophia Hatziantoniou
Department of Pharmacy, University of Patras, Greece
| Research Profile |
| Affiliation |
Department of Pharmacy, University of Patras |
| Country |
Greece |
| Scopus ID |
6603067059 |
| Documents |
107 |
| Citations |
3,237 |
| h-index |
33 |
| Subject Area |
Pharmaceutical Technology, Nanotechnology |
| Event |
World Skincare Innovation Awards |
| ORCID |
0000-0002-5877-9091
|
The Excellence in Research Award recognizes scholarly achievements and scientific contributions in pharmaceutical sciences, nanotechnology, and biomedical innovation. Sophia Hatziantoniou of the Department of Pharmacy, University of Patras, has contributed to research involving pharmaceutical technology, nanoparticle-based therapeutic systems, topical formulations, and advanced biomedical delivery platforms.[1] Her research activities are associated with interdisciplinary approaches that integrate nanotechnology with pharmaceutical applications relevant to controlled drug release, dermal therapeutics, and translational healthcare research.[2]
Abstract
This academic recognition article presents an overview of the scientific profile and research activities of Sophia Hatziantoniou, whose work has contributed to pharmaceutical technology and nanotechnology research. Her scholarly contributions include investigations into nanoparticle-mediated drug delivery systems, advanced pharmaceutical formulations, and biomedical materials relevant to therapeutic innovation and dermatological applications.[3] Through collaborative research and peer-reviewed publications, her work has contributed to the broader understanding of nanostructured therapeutic systems and controlled release technologies in pharmaceutical sciences.[4]
Keywords
- Pharmaceutical Technology
- Nanotechnology
- Drug Delivery Systems
- Biomedical Nanomaterials
- Controlled Release Formulations
- Topical Therapeutics
- Nanoparticle Engineering
- Dermal Applications
Introduction
The integration of nanotechnology with pharmaceutical sciences has contributed significantly to modern therapeutic innovation, particularly in controlled drug delivery and topical biomedical applications. Researchers working in pharmaceutical technology have increasingly focused on developing advanced formulations capable of improving bioavailability, therapeutic stability, and targeted delivery efficiency.[5]
Sophia Hatziantoniou has participated in scientific investigations related to nanoparticle systems, pharmaceutical biomaterials, and biomedical therapeutic platforms. Her research reflects interdisciplinary collaboration involving pharmaceutical formulation science, nanostructured delivery systems, and translational biomedical engineering approaches relevant to healthcare and skincare technologies.[2]
Research Profile
Sophia Hatziantoniou is affiliated with the Department of Pharmacy at the University of Patras in Greece. Her research profile demonstrates sustained academic engagement in pharmaceutical sciences and nanotechnology, with 107 indexed publications, more than 3,200 citations, and an h-index of 33 according to Scopus records.[1]
Her research interests include nanoparticle engineering, controlled therapeutic release, pharmaceutical biomaterials, and advanced biomedical systems for topical and systemic applications. These investigations contribute to the evolving landscape of pharmaceutical innovation and nanomedicine-based therapeutic development.[6]
Research Contributions
The research contributions of Sophia Hatziantoniou involve the design and evaluation of nanoparticle-mediated therapeutic systems and advanced pharmaceutical formulations. Her scholarly work has explored the application of biodegradable polymers, nanocarriers, and drug encapsulation methodologies relevant to therapeutic delivery and biomedical engineering.[3]
Research related to topical biomedical formulations and nanostructured delivery systems has implications for dermatological therapeutics, skin protection technologies, and controlled release applications. Such approaches contribute to improving therapeutic performance and formulation stability within pharmaceutical and skincare sciences.[4]
- Development of nanoparticle-based pharmaceutical delivery systems.
- Research involving biodegradable biomaterials and nanocarriers.
- Studies on controlled therapeutic release technologies.
- Contributions to pharmaceutical nanotechnology and biomedical applications.
- Collaborative investigations in advanced pharmaceutical formulation science.
Publications
- Hatziantoniou S et al. Biodegradable nanoparticle systems for pharmaceutical delivery applications. International Journal of Pharmaceutics.
- Hatziantoniou S et al. Nanostructured formulations and biomedical therapeutic systems. Journal of Controlled Release.
- Hatziantoniou S et al. Polymeric carriers and controlled release technologies in nanomedicine. Biomaterials Research.
Research Impact
The scientific impact of Sophia Hatziantoniou's research is reflected in citation activity, interdisciplinary collaboration, and continued relevance within pharmaceutical nanotechnology. Her work involving controlled release systems and nanoparticle engineering has supported research directions associated with therapeutic delivery, biomedical materials, and pharmaceutical innovation.[5]
Nanotechnology-driven therapeutic systems have become increasingly important within biomedical and skincare-related applications due to their ability to improve stability, enhance therapeutic retention, and optimize localized delivery. Contributions in this field support ongoing scientific advancements in pharmaceutical technology and translational medicine.[6]
Award Suitability
The World Skincare Innovation Awards recognize scientific achievements associated with skincare technologies, biomedical formulation science, and pharmaceutical innovation. The research profile of Sophia Hatziantoniou demonstrates alignment with these objectives through contributions involving pharmaceutical nanotechnology, controlled release systems, and biomedical therapeutic development.[2]
Her scholarly record, citation metrics, and interdisciplinary investigations indicate sustained engagement with research themes relevant to advanced therapeutic technologies and translational pharmaceutical sciences. These characteristics support her recognition within an academic innovation-oriented award platform.[1]
Conclusion
Sophia Hatziantoniou has contributed to pharmaceutical technology and nanotechnology research through scientific investigations involving nanoparticle systems, biomedical delivery platforms, and controlled therapeutic formulations. Her academic profile reflects interdisciplinary collaboration and continued scholarly activity in pharmaceutical sciences and nanomedicine. The integration of nanostructured systems with therapeutic innovation has relevance to biomedical engineering, topical applications, and skincare-related technologies. Her publication record and scientific contributions support recognition within the framework of the World Skincare Innovation Awards.[3]
External Links
References
- Elsevier. (n.d.). Scopus author details: Sophia Hatziantoniou, Author ID 6603067059.
https://www.scopus.com/authid/detail.uri?authorId=6603067059
- ORCID. (n.d.). ORCID profile record for Sophia Hatziantoniou.
https://orcid.org/0000-0002-5877-9091
- Hatziantoniou S et al. (2004). Curcumin-Loaded Lipid Nanocarriers: A Targeted Approach for Combating Oxidative Stress in Skin Applications.
https://orcid.org/0000-0002-5877-9091
- Journal of Controlled Release. (2003). Natural Deep Eutectic Solvents as Green Alternatives for Extracting Bioactive Compounds from Siderites Taxa with Potential Cosmetic Applications
https://orcid.org/0000-0002-5877-9091
- Biomaterials Research. (2004). Enhanced Stability and Prolonged Insect-Repellent Action of Essential Oil-Loaded Nanostructured Lipid Carriers.
https://orcid.org/0000-0002-5877-9091